Psychotropic medications and breastfeeding

Primary Psychiatry

Volumn 16, Issue 3, 2009, Pages 42-51

  Becker, Madeleine A ^a   Mayor, Geraldine F ^a   Kunkel, Elisabeth J S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CARBAMAZEPINE; CHLORPROMAZINE; CITALOPRAM; CREATINE; DIAZEPAM; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NORFLUOXETINE; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SERTRALINE; THYROTROPIN; TRAZODONE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ZOLPIDEM;

ABSENCE OF SIDE EFFECTS; ANEMIA; BREAST FEEDING; CARDIOMEGALY; CHILD DEVELOPMENT; COLIC; CRYING; CYANOSIS; DEVELOPMENTAL DISORDER; DROWSINESS; DRUG SAFETY; ELECTROCARDIOGRAM; FEEDING DISORDER; GENERALIZED ANXIETY DISORDER; HEART MURMUR; HUMAN; HYPOTHERMIA; JAUNDICE; LETHARGY; LIVER TOXICITY; MUSCLE HYPOTONIA; OBSESSIVE COMPULSIVE DISORDER; POSTTRAUMATIC STRESS DISORDER; PSYCHIATRIST; PUERPERAL DEPRESSION; PUERPERAL PSYCHOSIS; PUERPERIUM; RESPIRATION DEPRESSION; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SEIZURE; SIDE EFFECT; SLEEP DISORDER; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; THYROTROPIN BLOOD LEVEL; TREMOR; UREA NITROGEN BLOOD LEVEL; WEIGHT GAIN;

EID: 75649150268     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (185)

1. U.S. Food and Drug Administration. Summary of Proposed Rule on Pregnancy and Lactation Labeling. Available at: www.fda.gov/cder/regulatory/pregnancy- labeling/summary.htm. Accessed January 28, 2009.
2. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Use of Psychiatric Medications During Pregnancy and Lactation. 2007:87:1-20.
3. Kramer MS, Kakuma R. The optimal duration of exclusive breastfeeding: a systemic review. Adv Exp Med Biol. 2004;554:63-77.
4. Habicht JP; WHO Expert Consultation. Expert consultation on the optimal duration of exclusive breastfeeding: the process, recommendations, and challenges for the future. Adv Exp Med Biol. 2004;554:79-87.
5. Committee on Health Care for Underserved Women, American College of Obstetrics and Gynecologists. Breastfeeding: maternal and infant aspects. Obstet Gynecol. 2007;109(2 Pt 1):479-480.
6. Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane Database Syst Rev. 2002;(1):CD003517.
7. Gartner LM, Morton J, Lawrence RA, Naylor AJ, O'Hare D. Breastfeeding and use of human milk, section on breastfeeding. Pediatrics. 2005;15(2):496.
8. Ip S, Chung M, Raman G, et al. Breastfeeding and maternal and infant health outcomes in developed countries. Evid Rep Technol Assess (Full Rep). 2007;(153):1-186.
9. Leung AK, Sauve RS. Breast is best for babies. J Natl Med Assoc. 2005;97(7):1010-1019.
10. Chen A, Rogan WJ. Breastfeeding and the risk of postnatal death in the United States. Pediatrics. 2004;113(5):e435-e439.
11. Edmond KM, Zandoh C, Quigley MA, Amenga-Etego S, Owusu-Agyei S, Kirkwood BR. Delayed breastfeeding initiation increases the risk of infant mortality. Pediatrics. 2006;117(3):e380-e386.
12. Silfverdal SA, Bodin L, Olcen P. Protective effect of breastfeeding: an ecologic study of Haemophilus influenza meningitis and breastfeeding in an Swedish population study. Int J Epidemiol. 1999;28(1):152-156.
13. Hylander MA, Strobino DM, Dhanireddy R. Human milk feedings and infection among very low birth weight infants. Pediatrics. 1998;102(3):E38.
14. Howie PW, Forsyth JS, Ogston SA, Clark A, Florey CD. Protective effect of breast feeding against infection. BMJ. 1990;300(6716):11-16.
15. Beaudry M, Dufour R, Marcoux S. Relation between infant feeding and infections during the first six months of life. J Pediatr. 1995;126(2):191-197
16. Airfeen S, Black RE, Antelman G, Baqui A, Caulfield L, Becker S. Exclusive breastfeeding reduces acute respiratory infection and diarrhea deaths among infants in Dhaka slums. Pediatrics. 2001;108(4):E67.
17. Sisk PM, Lovelady CA, Dillard RG, Gruber KJ, O'Shea TM. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol. 2007;27(7):428-433.
18. Duffy, LC Faden H, Wasielewski R, Wolf J, Krystofik D. Exclusive breastfeeding protects against bacterial colonization and day care exposure to otitis media. Pediatrics. 1997;100(4):E7.
19. Duncan B, Ey J, Holberg CJ, Wright AL, Martinez FD, Taussig LM. Exclusive breast-feeding for at least 4 months protects against otitis media. Pediatrics. 1993;91(5):867-872.
20. Chantry CJ, Howard CR, Auinger P. Full breastfeeding duration and associated decrease in respiratory tract infection in US children. Pediatrics. 2006;117(2):425-432.
21. Cushing AH, Samet JM, Lambert WE, et al. Breastfeeding reduces the risk of respiratory illness in infants. Am J Epidemiol. 1998;147(9):863-870.
22. Marild S, Hansson S, Jodel U, Oden A, Swedberg K. Protective effect of breastfeeding against urinary tract infection. Acta Paediatr. 2004;93(2):164-168.
23. Piscane A, Graziano L, Mazzarella G, Scarpellino B, Zona G. Breastfeeding and urinary tract infection. J Pediatr. 1992;120(1):87-89.
24. Ortega-Garcia JA, Ferris-Tortajada J, Torres-Cantero AM, et al. Full breastfeeding and paediatric cancer. J Paediatr Child Health. 2008;44(1-2):10-13.
25. Daniels JL, Olshan AF, Pollack BH, Shah NR, Stram DO. Breastfeeding and neuroblastoma, USA and Canada. Cancer Causes Control. 2002;13(5):401-405.
26. Gerstein HC. Cow's milk exposure and type I diabetes mellitus. A critical overview of the clinical literature. Diabetes Care. 1994;17(1):13-19.
27. Gillman MW, Rifas-Shiman SL, Camargo CA Jr, et al. Risk of overweight among adolescents who were breastfed as infants. JAMA. 2001; 285(19):2461-2467.
28. Von Kries R, Koletzko B, Sauerwald T, et al. Breast feeding and obesity: cross sectional study. BMJ. 1999;319(7203):147-150.
29. Grummer-Strawn LM, Mei Z; Centers for Disease control and Prevention Pediatric Nutrition Surveillance System. Does breastfeeding protect against pediatric overweight? Analysis of longitudinal datat from the centers for disease control and prevention pediatric nutrition surveillance system. Pediatrics. 2004;113(2):e81-e86.
30. Bergmann KE, Bergmann RL, Von Kries R, et al. Early determinants of childhood overweight and adiposity in a birth cohort study: role of breast-feeding. Int J Obes Relat Metab Disor. 2003;27(2):162-172.
31. Armstrong J, Reilly JJ; Child Health Information Team. Breastfeeding and lowering the risk of childhood obestity. Lancet. 2002;359(9322):2003- 2004.
32. Kull I, Almqvist C, Lilja G, Pershagen G, Wickman M. Breast-feeding reduces the risk of asthma during the first 4 years of life. J Allergy Clin Immunol. 2004;14(4):755-760.
33. Oddy WH, Sherriff JL, De Klerk NH, et al. The relation of breastfeeding and body mass index to asthma and atopy in children: a prospective cohort study to age 6 years. Am J Public Health. 2004;94(9):1531-1537.
34. Oddy WH, Holt PG, Sly PD, et al. Association between breast feeding and asthma in 6 year old children. BMJ. 1999:319 (7213):815-819.
35. Kull I, Wickman M, Lilja G, Nordval SL, Pershagen G. Breast feeding and allergic diseases in infants-a prospective birth cohort study. Arch Dis Child. 2002;87(6):478-481.
36. Shah, PS, Aliwalas L, Shah V. Breastfeeding or breastmilk to alleviate procedural pain in neonates: a systematic review. Breastfeed Med. 2007;2(2):74-82.
37. Shah, PS, Aliwalas L, Shah V. Breastfeeding or breast milk for procedural pain in neonates. Cochrane Database Syst Rev. 2006 Jul 19;3:CD004950.
38. Mortensen El, Michaelsen KF, Sanders SA, Reinisch JM. The association between duration of breast feeding and adult intelligence. JAMA. 2002;287(18):2365-2371.
39. Silva AA, Mehta Z, O'Callaghan FJ. Duration of breast feeding and cognitive function: population based cohort study. Eur J Epidemiol. 2006;21(6):435-441.
40. Slykerman RF, Thompson JM, Becroft DM, et al. Breastfeeding and intelligence of preschool children. Acta Paeditr. 2005;94(7):827-829.
41. Elwood PC, Pickering J, Gallacher JE, Hughs J, Davies D. Long term effect of breastfeeding: cognitive function in the Caerphilly cohort. J Epidemiol Community Health. 2005;59(2):130-133.
42. Der G, Batty GD, Deary IJ. Effect of breast feeding on intelligence in children: prospective study, sibling pairs analysis, and meta-analysis. BMJ. 2006;333(7575):945.
43. Chau S, Arulkumaran S, Lim I, Selamat N, Ratnam SS. Influence of breastfeeding and nipple stimulation on postpartum uterine activity. Br J Obstet Gynaecol. 1994;101(9):804-805.
44. Kramer FM, Stunkard AJ, Marshall KA, KcKinney S. Liebschutz J. Breast-feeding reduces maternal lowerbody fat. J Am Diet Assoc. 1993;93(4):429-433.
45. Dewey KG, Heinig MJ, Norrsen LA. Maternal weight-loss patterns during prolonged laction. Am J Clin Nutr. 1993;58(2):162-166.
46. Chang-Claude J, Eby N, Kiechle M, Bastert G, Becher H. Breastfeeding and breast cancer risk by age 50 among women in Germany. Cancer Causes Control. 2000;11(8):687-695.
47. Layde PM, Webster LA, Baughman AL, Wingo PA, Rubin GL, Ory HW. The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol. 1989;42(10):963-973.
48. Shema L, Ore L, Ben-Shachar M, Haj M, Linn S. The association between breastfeeding and breast cancer occurrence among Israeli Jewish women: a case control study. J Cancer Res Clin Oncol. 2007;133(8):539-546.
49. Enger SM, Ross RK, Paganini-Hill A, Bernstien L. Breastfeeding experience and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 1998;7(5):365-369.
50. Enger SM, Ross RK, Henderson B, Bernstein L. Breastfeeding history, pregnancy experience and risk of breast cancer. Br J Cancer. 1997;76(1):118-123.
51. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collabora tive reanalysis of individual data from 47 epidemiological studies in 30 countries including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360(9328):187-195.
52. Danforth KN, Tworoger SS, Hecht JL, Rosner BA, Colditz GA, Haniknson SE. Breastfeeding and the risk of ovarian cancer in two prospective cohorts. Cancer Causes Control. 2007;18(5):517-523.
53. Siskind V, Green A, Bain C, Purdie D. Breastfeeding, menopause and epithelian ovarian cancer. Epidemiology. 1997;8(2):188-191.
54. Gwinn ML, Lee NC, Rhodes PH, Layde PM, Rubin GL. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol. 1990;43(6):559-568.
55. Ram KT, Bobby P, Hailpern SM, et al. Duration of lactation is associated with a lower prevalence of the metabolic syndrome in midlife-SWAN, the study of women's health across the nation. Am J Obstet Gynecol. 2008;198(3):268.e1-e6.
56. Ball TM, Wright AL. Health care costs of formula-feeding in the first year of life. Pediatrics. 1999;103(4 pt 2):870-876.
57. Eberhard-Gran M, Eskild A, Opjordsmoen S. Use of psychotropic medications in treating mood disorders during lactation. CNS Drugs. 2006;20(3):187-198.
58. Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychosis. Br J Psychiatry. 1987;150:662-673.
59. McNeil TF. A prospective study of postpartum psychoses in a high-risk group. 1. Clinical characteristics of the current postpartum episodes. Acta Pyschiatr Scand. 1986;74(2):205-216.
60. Newport DJ, Hostetter A, Arnold A, Stowe ZN. The treatment of postpartum depression: minimizing infant exposures. J Clin Psychiatry. 2002;63 Suppl 7:31-44.
61. Gentile S. Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index. Drug Saf. 2007;30(2):107-121.
62. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text rev. Washington, DC: American Psychiatric Association; 2000.
63. The International Statistical Classification of Diseases and Health Related Problems. 10th rev. 2nd ed. Geneva, Switzerland: World Health Organization; 2004.
64. Cox J. Postnatal mental disorder; towards ICD-11. World Psychiatry. 2004;3(2):96-97.
65. Nielsen Forman D, Videbech P, Hedegaard M, Dalby Salvig J, Secher NJ. Postpartum depression: identification of women at risk. BJOG. 2000;107(10):1210-1217.
66. Bloch M, Rotenberg N, Koren D, Klein E. Risk factors associated with the development of postpartum mood disorders. J Affec Disord. 2005;88(1):9-18.
67. Hales RE, Yudofsky SC, eds. American Psychiatric Publishing Textbook of Clinical Psychiatry. 4th ed. Arlington, VA: American Psychiatric Publishing; 2005.
68. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy and in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295(5):499-507.
69. Gentile S. Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother. 2004;38(7-8):1265-1271.
70. Spinelli MG. A systemic investigation of 16 cases of neonaticide. Am J Psychiatry. 2001;158(5):811-813.
71. Nager A, Sundquist K, Ramirez-Leon V, Johansson LM. Obstetric complications and postpartum psychosis: a follow-up study of 1.1 million first time mothers between 1975 and 2003 in Sweden. Acta Psychiatr Scand. 2008;117(1):12-19.
72. Harlow BL, Vitonis AF, Sparen P, Cnattingius S, Joffe H, Hultman CM. Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal hospitalizations. Arch Gen Psychiatry. 2007;64(1):42-48.
73. Ross LE, McLean LM. Anxiety disorders during pregnancy and the postpartum period: a systematic review. J Clin Psychiatry. 2006;67(8):1285-1298.
74. Cohen MM, Ansara D, Schei B, Stuckless N, Stewart DE. Posttraumatic stress disorder after pregnancy, labor and delivery. J Womens Health (Larchmt). 2004;13(3):315-324.
75. Maggioni C, Margola D, Filippi F. PTSD, risk factors, and expectations among women having a baby: a two wave longitudinal study. J Psychosom Obstet Gynaecol. 2006;27(2):81-90.
76. Zaers S, Waschke M, Ehlert U. Depressive symptoms and symptoms of post-traumatic stress disorder in women after childbirth. J Psychosom Obstet Gynaecol. 2008;29(1):61-71.
77. Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal compliations in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry. 2005;162(1):79-91.
78. Nilsson E, Lichenstein P, Cnattingius S, Murray RM, Hultman CM. Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr Res. 2002;58(2-3):221-229.
79. Zuckerman B, Bauchner H, Parker S, Cabral H. Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Pediatr. 1990;11(4):190-194.
80. Gao W, Paterson J, Abbott M, Carter S, Iusitini L. Maternal mental health and child behaviour problems at 2 years, findings from the Pacific Islands Families Study. Aust N S J Psychiatry. 2007;41(11):885-895.
81. Minkovitz CS, Strobino D, Scharfstein D, Hou W, Miller T, Mistry KB, Swartz K. Maternal depressive symptoms and children's receipt of health care in the first 3 years of life. Pediatrics. 2005;115(2):306-314.
82. Hatton DC, Harrison-Hohner J, Coste S, et al. Symptoms of postpartum depression and breastfeeding. J Hum Lac. 2005;21(44):444-449.
83. McLearn KT, Minkovitz CS, Strobino DM, Marks E, Hou W. Maternal depressive symptoms at 2 to 4 months post partum and early parenting practices. Arch Pediatr Adolesc Med. 2006;160(3):279-284.
84. Paulson JF, Dauber S, Leiferman JA. Individual and combined effects of postpartum depression in mothers and fathers on parenting behavior. Pediatrics. 2006;118(2):659-668.
85. Pilowsky DJ, Wickramaratne PJ, Rush AJ, et al. Children of currently depressed mothers: a STAR*D ancillary study. J Clin Psychiatry. 2006;67(1):126-136.
86. Biederman J, Faraone SV, Hirshfel-Becker DR, Friedman D, Robin JA, Rosenbaum JF. Patterns of psychopathology and dysfunction in high-risk children of parents with panic disorder and major depression. Am J Psychiatry. 2001;158(1):49-57.
87. Brennan PA, Hammen C, Anderson MJ, Bor W, Najman JM, Williams GM. Chronicity, severity, and timing of maternal depressive symptoms: relationships with child outcomes at age 5. Dev Psychol. 2000;36(6):759-766.
88. Hammen C, Brennan PA. Severity, chronicity and timing of maternal depression and risk for adolescent offspring diagnosis in a community sample. Arch Gen Psychiatry. 2003;60(3):253-258.
89. Weissman MM, Pilowsky DJ, Wickramaratne PJ, et al. Remissions in maternal depression and child psychopathology:a STAR*D-child report. JAMA. 2006;295(12):1389-1398.
90. American Academy of Pediatrics, Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108(3):776-789.
91. Weissman, AM, Levy BT, Hartz AJ, et al. Pooled analyis of antidepressant levels in lactating mothers, breast milk and nursing infants. Am J Psychiatry. 2004;161(6):1066-1078.
92. Berle, J0, Steen VM, Aamo TO, Breilid H, Zahlsen K, Spigset O. Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors infant exposure, clinical symptoms, and cytochrome p450 genotypes. J Clin Psychiatry. 2004;65(9):1228-1234.
93. Hendrick V, Stowe ZN, Alshuler LL, et al. Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk. Biol Psychiatry. 2001;50(10):775-782.
94. Yoshida K, Smith B, Craggs M, Kumar RC. Fluoxetine in breast milk and developmental outcome of breastfed infants. Br J Psychiatry. 1998;172:175-178.
95. Taddio A, Ito S, Koren G. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol. 1996;36(1):42-47.
96. Heikkinen T, Ekblad U, Palo P, Laine K. Pharmokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clin Pharmacol Ther. 2003;73(4):330-337.
97. Hale TW, Shum S, Grossberg M. Fluoxetine toxicity in a breastfed infant. Clin Pediatr. 2001;40(12):681-684.
98. Kristensen JH, Ilett KF, Hackett LP, Yapp P, Paech M, Begg EJ. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmaacol. 1999;48(4):521-527.
99. Lester BM, Cucca J, Andreozzi L, Flanagan P, Oh W. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry. 1993;32(6):1253-1255.
100. Hendrick V, Fukuchi A, Alshuler L, Widawski M, Wertheimer A, Brunhuber MV. Use of sertraline, paroxetine and fluvoxoamine by nursing women. Br J Psychiatry. 2001;179:163-166.
101. Mammen OK, Perel JM, Rudolph G, Foglea JP, Wheeler SB. Sertraline and norsertraline levels in three breastfed infants. J Clin Psychiatry. 1997;58(3):100-103.
102. Stowe ZN, Owens MJ, Landry JC, et al. Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry. 1997;154(9):1255-1260.
103. Kristensen JH, Ilett KF, Dusci LJ, et al. Distribution and excretion of sertraline and N-desmithylsertraline in human milk. Br J Clin Pharmacol. 1998;45(5):453-457.
104. Wisner KL, Perel JM, Blumer J. Serum sertraline and N-desmethylsertraline levels in breast feeding mother-infant pairs. Am J Psychiatry. 1998;155(5):690-692.
105. Stowe SN, Hostetter Al, Owens MJ, et al. The pharmokinetics of sertraline excretion into human breast milk:determinants of infant serum concentrations. J Clin Psychiatry. 2003;64(1):73-80.
106. Epperson N, Czarkowski KA, Ward-O'Brian D, et al. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am J Psychiatry. 2001;158(10):1631-1637.
107. Spigset O, Carieborg L, Ohman R, Norstrom A. Excretion of citalopram in breast milk. Br J Clin Pharmacol. 1997;44(3):295-298.
108. Schmidt K, Oleson OV, Jensen PN. Citalopram and breast-feeding:serum concentration and side effects in the infant. Biol Psychiatry. 2000;47(2):164-165.
109. Heikkinen T, Ekblad U, Kero P, Ekblad S, Laine K. Citalopram in pregnancy and lacation. Clin Pharmacol Ther. 2002;72(2):184-191.
110. Rampono J, Kristensen JH, Hackett LP, Paech M, Kohan R, Ilett KF. Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants. Br J Clin Pharmacol. 2000;50(3):263-268.
111. Lee A, Woo J, Ito S. Frequency of infant adverse events that are associated with citalopram use during breast-feeding. Am J Obstet. 2004;190(1):218-221.
112. Rampono J, Hackett LP, Kristensen JH, Kohan R, Page-Sharp, Ilett KF. Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk. Br J Clin Pharmacol. 2006;62(3):316-322.
113. Gentile S. Escitalopram late in pregnancy and while breast-feeding. Ann Pharmacother. 2006;40(9):1696-1697.
114. Castberg I, Spigset O. Excretion of escitalopram in breastmilk. J Clin Pyschopharmacol. 2006;26(5):536-538.
115. Kristensen JH, Hackett LP, Kohan R, Paech M, Ilett KF. The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants. J Hum Lact. 2002;18(2):139-143.
116. Arnold LM, Suckow RF, Lichtenstein PK. Fluvoxamine concentrations in breast milk and in maternal and infant sera. J Clin Psychopharmacol. 2000;20(4):491-493.
117. Wright S, Dawling S, Ashford JJ. Excretion of Fluvoxamine in breast milk. Br J Clin Pharmacol. 1991;31(2):209.
118. Hagg S, Greenberg K, Carleborg L. Excretion of Fluvoxamine into breast milk. Br J Clin Pharmacol. 2000;49(3):286-288.
119. Piontek CM, Wisner KL, Perel JM, Peindl KS. Serum fluvoxamine levels in breastfed infants. J Clin Psychiatry. 2001;62(2):111-113.
120. Ohman R, Hagg S, Carleborg L, Spigset O. Excretion of paroxetine into breast milk. J Clin Psychiatry. 1999;60(8):519-523.
121. Misri S, Kim J, Riggs KW, Kostaras X. Paroxetine levels in postpartum depressed women, breast milk, and infant serum. J Clin Psychiatry. 2000;61(11):828-832.
122. Stowe SN, Cohen LS, Hostetter A, Ritchie JC, Owens MJ, Nemeroff CB. Paroxetine in human breastmilk and nursing infants. Am J Psychiatry. 2000;157(2):185-189.
123. Merlob P, Stahl B, Sulkes J. Paroxetine during breast-feeding: infant weight gain and maternal adherence to counsel. Eur J Pediatr. 2004;163(3):135-139.
124. Yoshida K, Smith B, Craggs M, Kumar RC. Investigation of pharmokinetics and possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk. J Affect Disord. 1997;43(3):225-237.
125. Wisner KL, Perel JM, Foglia JP. Serum clomipramine and metabolite levels in four nursing mother-infant pairs. J Clin Psychiatry. 1995;56(1):17-20.
126. Matheson I, Pande H, Alertsen AR. Respiratory depression caused by N-Desmethyldoxepin in breast milk. Lancet. 1985;2(8464):1124.
127. Frey OR, Scheidt P, von Brenndorff AI. Adverse effects in a newborn infant breast-fed by a mother treated with doxepin. Ann Pharmacother. 1999;33(6):690-693.
128. Wisner KL, Perel JM. Serum nortriptyline levels in nursing mothers and their infants. Am J Psychiatry. 1991;148(9):1234-1236.
129. Wisner KL, Perel JM, Findling RL, Hinnes RL. Nortriptyline and its hydroxymetabolites in breastfeeding mothers and newborns. Psychopharmacol Bull. 1997;33(2):249-251.
130. Ilett KF, Kristensen JH, Hackett LP, Paech M, Kohan R, Rampono J. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. Br J Clin Pharmacol. 2002;53(1):17-22.
131. Hendrick V, Alshuler L, Wertheimer A, Dunn WA. Venlafaxine and breast-feeding. Am J Psychiatry. 2001;158(12):2089-2090.
132. Ilett KF, Hackett LP, Dusci LJ, et al. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br J Clin Pharmacol. 1998;45(5):459-462.
133. Baab SW, Peindl KS, Wisner KL. Serum buproprion levels in 2 breastfeeding mother-infant pairs. J Clin Psychiatry. 2002;63(10):910-911.
134. Briggs GG, Samson JH, Ambrose PJ, Schroeder DH. Excretion of buproprion in breast milk. Ann Pharmacother. 1993;27(4):431-433.
135. Chaudron LH, Schoenecker CJ. Buproprion and breastfeeding: a case of a possible infant seizure. J Clin Psychiatry. 2004;65:6:881-882.
136. Verbeeck RK, Ross SG, McKenna EA. Excretion of trazadone in breast milk. Br J Clin Pharmacol. 1986;22(3):367-370.
137. Kristensen JH, Ilett KF, Rampono J, Kohan R, Hackett LP. Transfer of the antidepressant mirtazapine into breast milk. Br J Clin Pharmacol. 2007;63(3):322-327.
138. Klier CM, Mossaheb N, Lee A, Zernig G. Mirtazepine and breastfeeding: maternal and infant plasma levels. Am J Psychiatry. 2007;164(2):348-349.
139. Aichhorn W, Whitworth AB, Weiss U, Stuppaeck C. Mirtazapine and breastfeeding. Am J Psychiatry. 2004;161(12):2325.
140. McElhatton PR. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol. 1994;8(6):461-475.
141. Wretlind M. Excretion of oxazepam in breastmilk. Eur J Clin Pharmacol. 1987;33(2):209-210.
142. Summerfield RJ, Nielsen MS. Excretion of lorazepm into breast milk. Br J Anaesth. 1985;57(10):1042-1043.
143. Dusci LJ, Good SM, Hall RW, Ilett KF. Excretion of diazepam and its metabolites in human milk during withdrawl from combination high dose diazepam and oxazepam. Br J Clin Pharmacol. 1990;29(1):123-126.
144. Oo CY, Kuhn RJ, Desai N, Wright CE, McNamara PJ. Pharmokinetics in lactating women: predication of alprazolam transfer into milk. Br J Clin Pharmacol. 1995;40(3):231-236.
145. Borgotta L, Jenny RW, Gruss L, Ong C, Barad D. Clinical significance of methohexital, meperidine, and diazepam in breast milk. J Clin Pharmacol. 1997;37(3):186-192.
146. Brandt R. Passage of diazepam and desmethyldiazepam into breast milk. Arzneimittelforschung. 1976;26(3):454-457.
147. Patrick MJ, Tilstone WJ, Reavey P. Diazepam and breast-feeding. Lancet. 1972;1(7749):542-543.
148. Wesson DR, Camber S, Harkey M, Smith DE. Diazepam and desmethyldiazepam in breast milk. J Pschoactive Drugs. 1985;17(1):55-56.
149. Pons G, Francoual C, Guillet P, Moran C, Hermann P, bianchetti G, Thiercelin JF, Thenot JP, Olive G. Zolpidem excretion in breast milk. Eur J Clin Pharmacol. 1989;37(3):245-248.
150. Sykes PA, Quarrie J, Alexander FW. Lithium carbonate and breast-feeding. Br Med J. 1976;2(6047):1299.
151. Schou M, Amdison A. Lithium and pregnancy. Lithium ingestion by children breast-fed by women on lithium treatment. Br Med J. 1973;2(5859):138.
152. Viguera AC, Newport DJ, Ritchie J, et al. Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry. 2007;164(2):342-345.
153. Tunnessen WW Jr, Hertz CG. Toxic effects of lithium in newborn infants: a commentary. J Pediatr. 1972;81(4):804-807.
154. Woody JN, London WL, WIlbanks GD Jr. Lithium toxicity in a newborn. Pediatrics. 1971;47(1):94-96.
155. Moretti ME, Koren G, Verjee Z, Ito S. Monitoring lithium in breast milk: an individualized approach for breast-feeding mothers. Ther Drug Monit. 2003;25(3):364-366.
156. Nau H, Rating D, Koch S, Hauser I, Helge H. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther. 1981;219(3):768-777.
157. Piontek CM, Baab S, Peindl KS, Wisner KL. Serum valproate levels in 6 breastfeeding mother-infant pairs. J Clin Psychiatry. 2000;61(3):170-172.
158. Wisner KL, Perel JM. Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs. J Clin Psychopharmacol. 1998;18(2):167-169.
159. Philbert A, Pedersen B, Dam M. Concentration of valproate during pregnancy, in the newborn and in breast milk. Acta Neurol Scand. 1985;72(5):460-463.
160. Stahl MM, Neiderud J, Vinge E. Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. J Pediatr. 1997;130(6):1001-1003.
161. Niebyl JR, Blake DA, Freeman JM, Luff RD. Carbamazepine levels in pregnancy and lactation. Obstet Gynecol. 1979;53(1):139-140.
162. Merlob P, Mor N, Litwin A. Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breastfeeding. Ann Pharmacother. 1992;26(12):1563-1565.
163. Frey B, Schubiger G, Musy JP. Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breastfeeding. Eur J Pediatr. 1990;150(2):136-138.
164. Frey B, Braegger CP, Ghelfi D. Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding. Ann Pharmacother. 2002;36(4):644-647.
165. Liporace J, Kao A, D'Abreu. Concerns regarding lamotrigine and breast feeding. Epilepsy Behav. 2004;5(1):102-105.
166. Tomson T, Ohman I, Vitols S. Lamotrigine in pregnancy and lactation: a case report. Epilepsia. 1997;38(9):1039-1041.
167. Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmokinetics during delivery, in the neonate and during lactation. Epilepsia. 2000;41(6):709-713.
168. Rubin ET, Lee A, Ito S. When breastfeeding mothers need CNS-acting drugs. Can J Clin Pharmacol. 2004;11(2):e257-e266.
169. Rambeck B, Kurlemann G, Stodieck SR, May TW, Jurgens U. Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur J Clin Pharmacol. 1997;51(6):481-484.
170. Whalley LJ, Blain PG, Prime JK. Haloperidol secreted in breast milk. Br Med J (Clin Res Ed). 1981;282(6278):1746-1747.
171. Yoshida K, Smith B, Craggs M, Kumar R. Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants. Psychol Med. 1998;28(1):81-91.
172. Wiles DH, Orr MW, Kolakowska T. Chorpromazine levels in plasma and milk of nursing mothers. Br J Clin Pharmacol. 1978;5(3):272-273.
173. Kris EB, Carmichael DM. Chlorpromazine maintenance therapy during pregnancy and confinement. Psychiatr Q. 1957;31(4):690-695.
174. Aichhorn W, Stuppaech C, Whitworth AB. Risperdone and breast-feeding. J Psychopharmacol. 2005;19(2):211-213.
175. Illett KF, Hackett LP, Kristensen JH, Waddadi KS, Gardiner SJ, Begg EJ. Transfer of risperidone and 9-hydroxyrisperdone into human milk. Ann Pharmacother. 2004;38(2):273-276.
176. Hill RC, McIvor RJ, Wojnar-Horton RE, Hackett LP, Ilett KF. Risperidone distribution and excretion into human milk: a case report and estimated infant exposure during breast feeding. J Clin Psychopharmacol. 2000;20(2):285-286.
177. Gardiner SJ, Kristensen JH, Begg EJ, et al. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am J Psychiatry. 2003;160(8):1428-1431.
178. Croke S, Buist A, Hackett LP, Ilett KF, Norman TR, Burrows GD. Olanzapine excretion in human breast milk: estimation of infant exposure. Int J Neuropsychopharmacol. 2002;5(3):243-247.
179. Goldstein DJ, Corbin LA, Fung MC. Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol. 2000;20(4):399-403.
180. Lee A, Gliesbrecht E, Dunn E, Ito S. Excretion of quetiapine in breast milk. Am J Psychiatry. 2004;161(9):1715-1716.
181. Rampono J, Kristensen JH, Ilett KF, Hackett LP, Kohan R. Quetiapine and breast feeding. Ann Pharmacother. 2007;41(4):711-714.
182. Barnas C, Bergant A, Hummer M, Saria A, Fleishchhacker WW. Clozapine concentrations in maternal and fetal plasma, amniotic fluid and breast milk. Am J Psychiatry. 1994;151(6):945.
183. Mendheker DN. Possible delayed speech acquisition with clozapine therapy during pregnancy and lactation. J Neuropsychiatry Clin Neurosci. 2007;19(2):196-197.
184. Jain AI, Lacy T. Psychotropic drugs in pregnancy and lactation. J Psychiatr Pract. 2005;11:(3):177-191.
185. Committee on Health Care for Underserved Women, American College of Obstetrics and Gynecologists. ACOG Committee Opinion No 361: Breastfeeding: maternal and infant aspects. Obstet Gynecol. 2007;109(2 Pt 1):479-480.